Human polymorphisms in GSDMD alter the inflammatory response

Exomic studies have demonstrated that innate immune genes exhibit an even higher degree of variation than the majority of other gene families. However, the phenotypic implications of this genetic variation are not well understood, with effects ranging from hypomorphic to silent to hyperfunctioning....

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry Vol. 295; no. 10; pp. 3228 - 3238
Main Authors: Rathkey, Joseph K., Xiao, Tsan S., Abbott, Derek W.
Format: Journal Article
Language:English
Published: United States Elsevier Inc 06-03-2020
American Society for Biochemistry and Molecular Biology
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Exomic studies have demonstrated that innate immune genes exhibit an even higher degree of variation than the majority of other gene families. However, the phenotypic implications of this genetic variation are not well understood, with effects ranging from hypomorphic to silent to hyperfunctioning. In this work, we study the functional consequences of this variation by investigating polymorphisms in gasdermin D, the key pyroptotic effector protein. We find that, although SNPs affecting potential posttranslational modifications did not affect gasdermin D function or pyroptosis, polymorphisms disrupting sites predicted to be structurally important dramatically alter gasdermin D function. The manner in which these polymorphisms alter function varies from conserving normal pyroptotic function to inhibiting caspase cleavage to disrupting oligomerization and pore formation. Further, downstream of inflammasome activation, polymorphisms that cause loss of gasdermin D function convert inflammatory pyroptotic cell death into immunologically silent apoptotic cell death. These findings suggest that human genetic variation can alter mechanisms of cell death in inflammation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by Luke O'Neill
Supported by NIGMS, National Institutes of Health Grant T32 GM007250.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.RA119.010604